查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948321

2026年全球症候群多重診斷市場報告

Syndromic Multiplex Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，多重診斷市場發展迅速，預計到2025年將達到34.3億美元，到2026年將達到37.6億美元，複合年成長率為9.6%。過去幾年成長要素包括：多重診斷的普及程度有限、對傳統單一病原體檢測的依賴、感染疾病負擔日益加重、臨床檢查室投資不斷增加以及基於PCR技術的早期應用。

預計未來幾年，多重診斷市場規模將強勁成長，到2030年將達到54.2億美元，複合年成長率（CAGR）為9.6%。預測期內的成長要素包括高通量多重平台的發展、與基於人工智慧的數據分析的整合、臨床和研究實驗室的擴張、對快速傳染病篩檢日益成長的需求，以及互聯診斷解決方案和雲端平台的普及應用。預測期內的關鍵趨勢包括多重PCR和核酸擴增技術（NAT）的日益普及、對快速準確感染疾病診斷的需求不斷成長、次世代定序應用的發展、基於雲端的診斷平台和軟體服務的擴展，以及檢查室中自動化樣本到結果系統的整合。

預計未來幾年，感染疾病的日益普及將推動多重診斷市場的成長。感染疾病是指有害微生物（例如細菌、病毒、真菌和寄生蟲）侵入人體並在體內繁殖，從而引起症狀和健康併發症的疾病。感染疾病的增加感染疾病從單一檢體中快速、同時檢測多種病原體，有助於控制傳染病。這提高了診斷的準確性和速度，有助於及時做出治療決策，並改善患者的治療效果。例如，總部位於瑞典的政府機構歐洲疾病預防控制中心（ECDC）在2025年11月報告稱，2025年共發生266,165例屈公病（CHIKVD）病例，其中118例死亡。比2024年下降了35.2%，南美洲的巴西受影響最為嚴重。因此，感染疾病的增加趨勢正在推動多重診斷市場的成長。

症候群多重診斷領域的主要企業正致力於開發技術先進的解決方案，包括人工智慧驅動的診斷演算法，以提高病原體檢測的速度、準確性和覆蓋範圍。人工智慧增強型診斷演算法是先進的計算工具，特別是那些採用機器學習和深度學習技術的演算法，能夠分析複雜的臨床和實驗室數據，從而實現更快、更準確的疾病診斷。例如，總部位於荷蘭的分子診斷公司Qiagen NV於2024年1月為其QIAstat-Dx平台推出了兩款症候群檢測組合：「胃腸道組合2」和「腦膜炎和腦炎組合」。這些組合能夠在一次檢測中快速且準確地檢測多種病原體，從而為臨床決策提供支援並改善患者預後。 QIAstat-Dx系統還整合了先進的數據分析功能，可協助醫療專業人員有效率地識別和管理感染疾病爆發。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球症候群多重診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 多重PCR和NAT技術的應用日益廣泛
    • 對快速準確診斷感染疾病的需求日益成長
    • 次世代定序應用的發展
    • 擴展基於雲端的診斷平台和軟體服務
    • 在檢查室中整合自動化樣本到結果系統

第5章 終端用戶產業市場分析

  • 臨床檢查室
  • 醫院
  • 製藥和生物技術公司
  • 研究所
  • 政府和公共衛生機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球症候群多重診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球症候群多重診斷市場規模、對比及成長率分析
  • 全球症候群多重診斷市場表現：規模與成長，2020-2025年
  • 全球症候群多重診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 儀器、試劑、軟體和服務
  • 依檢體類型
  • 血液檢體、尿液檢體、唾液檢體、組織檢體
  • 透過技術
  • 聚合酵素鏈鎖反應、質譜分析、核酸增幅檢查、次世代定序
  • 透過使用
  • 感染疾病、呼吸系統疾病、消化系統疾病、性行為感染、中樞神經系統疾病
  • 最終用戶
  • 臨床檢查室、醫院、製藥和生物技術公司、研究機構及其他最終用戶
  • 按類型細分：設備
  • 即時聚合酵素鏈鎖反應(PCR) 系統、微流體控系統、自動化樣本到結果系統、基於晶片的系統、多重聚合酵素鏈鎖反應(PCR) 平台
  • 按類型細分：試劑
  • 檢測板、引子和探針、酵素、緩衝液和溶液、樣品製備試劑
  • 按類型細分：軟體和服務
  • 數據分析軟體、基於雲端的診斷平台、整合和連接解決方案、技術支援服務、維護和校準服務、培訓和實施服務

第10章 區域與國家分析

  • 全球症候群多重診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球症候群多重診斷市場：依國家、績效及預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 症候群多重診斷市場：競爭格局及市場佔有率（2024 年）
  • 症候群多診斷市場：公司估值矩陣
  • 症候群多重診斷市場：公司概況
    • Roche Molecular Systems Inc.
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Hologic Inc.
    • Bio-Rad Laboratories Inc.

第37章：其他領先和創新企業

  • Qiagen NV, Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年症候群多重診斷市場：提供新機會的國家
  • 2030年症候群多重診斷市場：提供新機會的細分市場
  • 2030年症候群多重診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MSMDU01_G26Q1

Syndromic multiplex diagnostics is a molecular testing approach that simultaneously detects and identifies multiple pathogens or biomarkers linked to a particular syndrome from a single patient sample. This approach employs multiplex polymerase chain reaction (PCR) or comparable technologies to provide rapid and comprehensive results. By identifying multiple potential causes at once, these diagnostics support timely and accurate diagnosis of infectious diseases, enhancing clinical decision-making and patient outcomes.

The primary product categories in syndromic multiplex diagnostics include instruments, reagents, software, and services. Syndromic multiplex diagnostic instruments are sophisticated molecular testing systems designed to detect multiple pathogens simultaneously from a single patient sample, using integrated platforms such as real-time polymerase chain reaction (PCR) or microfluidics for fast and precise disease diagnosis. The types of samples analyzed include blood, urine, saliva, and tissue. These diagnostics employ various technologies, including polymerase chain reaction (PCR), mass spectrometry, nucleic acid amplification tests, and next-generation sequencing, and are applied in areas such as infectious diseases, respiratory diseases, gastrointestinal diseases, sexually transmitted infections, and central nervous system diseases. Their end users include clinical laboratories, hospitals, pharmaceutical and biotechnology companies, research institutes, and other organizations.

Tariffs are impacting the syndromic multiplex diagnostics market by increasing costs of imported instruments, reagents, and automated diagnostic platforms. Segments such as PCR systems, microfluidic-based systems, and assay panels are particularly impacted, with Asia-Pacific regions including China and India facing the highest import duties. This has led to higher operational costs and slowed adoption in some regions. On the positive side, tariffs encourage local manufacturing, innovation in reagent development, and investment in domestic diagnostic solutions.

The syndromic multiplex diagnostics market research report is one of a series of new reports from The Business Research Company that provides syndromic multiplex diagnostics market statistics, including syndromic multiplex diagnostics industry global market size, regional shares, competitors with a syndromic multiplex diagnostics market share, detailed syndromic multiplex diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the syndromic multiplex diagnostics industry. This syndromic multiplex diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The syndromic multiplex diagnostics market size has grown strongly in recent years. It will grow from $3.43 billion in 2025 to $3.76 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to limited access to multiplex diagnostics, reliance on conventional single-pathogen tests, growing burden of infectious diseases, increasing investments in clinical laboratories, early adoption of pcr-based technologies.

The syndromic multiplex diagnostics market size is expected to see strong growth in the next few years. It will grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to development of high-throughput multiplex platforms, integration with ai-powered data analysis, expansion of clinical and research laboratories, rising demand for rapid infectious disease screening, adoption of connected diagnostic solutions and cloud platforms. Major trends in the forecast period include rising adoption of multiplex pcr and naat technologies, increasing demand for rapid and accurate infectious disease diagnosis, growth in next-generation sequencing applications, expansion of cloud-based diagnostic platforms and software services, integration of automated sample-to-answer systems in laboratories.

The rising prevalence of infectious diseases is expected to drive the growth of the syndromic multiplex diagnostics market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and multiply, resulting in symptoms and health complications. The increase in infectious diseases is fueled by greater global travel, which accelerates the spread of pathogens across borders and populations. Syndromic multiplex diagnostics support infectious disease management by enabling rapid, simultaneous detection of multiple pathogens from a single sample. They enhance diagnostic accuracy and speed, facilitating timely treatment decisions and improved patient outcomes. For example, in November 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported 266,165 CHIKVD cases and 118 deaths in 2025, representing a 35.2% decline from 2024, with Brazil in South America being the most affected. Therefore, the increasing prevalence of infectious diseases is driving the growth of the syndromic multiplex diagnostics market.

Leading companies in the syndromic multiplex diagnostics sector are concentrating on developing technologically advanced solutions, including AI-powered diagnostic algorithms, to improve the speed, accuracy, and breadth of pathogen detection. AI-enhanced diagnostic algorithms are sophisticated computational tools that use artificial intelligence, particularly machine learning and deep learning methods, to analyze complex clinical and laboratory data for faster and more precise disease diagnosis. For instance, in January 2024, Qiagen N.V., a molecular diagnostics company based in the Netherlands, launched two syndromic testing panels, the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel for its QIAstat Dx platform. These panels allow rapid and accurate detection of multiple pathogens in a single test, aiding clinical decision-making and improving patient outcomes. The QIAstat-Dx system also incorporates advanced data analytics, helping healthcare professionals efficiently identify and manage infectious disease outbreaks.

In March 2025, ABL Diagnostics, a France-based molecular diagnostics company, formed a partnership with Riken Genesis. The collaboration aims to expand microbiology genotyping in Japan by promoting and commercializing ABL Diagnostics' DeepChek and UltraGene molecular assays across Japanese laboratories. Riken Genesis, a Japan-based genetic analysis and diagnostics company, specializes in syndromic multiplex diagnostics.

Major companies operating in the syndromic multiplex diagnostics market are Roche Molecular Systems Inc., Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

North America was the largest region in the syndromic multiplex diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syndromic multiplex diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the syndromic multiplex diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The syndromic multiplex diagnostics market consists of revenues earned by entities by providing services such as diagnostic workflow integration services, remote testing, clinical decision support tools for syndromic testing, and regulatory and compliance support for diagnostic labs. The market value includes the value of related goods sold by the service provider or included within the service offering. The syndromic multiplex diagnostics market also includes sales of multiplex diagnostic instruments, reagents and consumables, software, and accessories used for the simultaneous detection of multiple pathogens. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Syndromic Multiplex Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses syndromic multiplex diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for syndromic multiplex diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The syndromic multiplex diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
  • 2) By Sample Type: Blood Samples; Urine Samples; Saliva Samples; Tissue Samples
  • 3) By Technology: Polymerase Chain Reaction; Mass Spectrometry; Nucleic Acid Amplification Tests; Next-Generation Sequencing
  • 4) By Application: Infectious Diseases; Respiratory Diseases; Gastrointestinal Diseases; Sexually Transmitted Infections; Central Nervous System Diseases
  • 5) By End User: Clinical Laboratories; Hospitals; Pharmaceutical And Biotechnology Companies; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems; Microfluidic-Based Systems; Automated Sample-To-Answer Systems; Cartridge-Based Systems; Multiplex Polymerase Chain Reaction (PCR) Platforms
  • 2) By Reagents: Assay Panels; Primers And Probes; Enzymes; Buffers And Solutions; Sample Preparation Reagents
  • 3) By Software And Services: Data Analysis Software; Cloud-Based Diagnostic Platforms; Integration And Connectivity Solutions; Technical Support Services; Maintenance And Calibration Services; Training And Installation Services
  • Companies Mentioned: Roche Molecular Systems Inc.; Abbott Laboratories; Becton Dickinson and Company; Hologic Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Cepheid; Bosch Healthcare Solutions GmbH; Biocartis NV; Luminex Corporation; Curetis GmbH; Accelerate Diagnostics Inc.; Applied BioCode Inc.; Ador Diagnostics Ltd.; Akonni Biosystems Inc.; Alveo Technologies Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; Nanomix Inc.; Primerdesign Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Syndromic Multiplex Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Syndromic Multiplex Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Syndromic Multiplex Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Syndromic Multiplex Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex Pcr And Naat Technologies
    • 4.2.2 Increasing Demand For Rapid And Accurate Infectious Disease Diagnosis
    • 4.2.3 Growth In Next-Generation Sequencing Applications
    • 4.2.4 Expansion Of Cloud-Based Diagnostic Platforms And Software Services
    • 4.2.5 Integration Of Automated Sample-To-Answer Systems In Laboratories

5. Syndromic Multiplex Diagnostics Market Analysis Of End Use Industries

  • 5.1 Clinical Laboratories
  • 5.2 Hospitals
  • 5.3 Pharmaceutical And Biotechnology Companies
  • 5.4 Research Institutes
  • 5.5 Government And Public Health Agencies

6. Syndromic Multiplex Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Syndromic Multiplex Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Syndromic Multiplex Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Syndromic Multiplex Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Syndromic Multiplex Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Syndromic Multiplex Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Syndromic Multiplex Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Syndromic Multiplex Diagnostics Market Segmentation

  • 9.1. Global Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents, Software And Services
  • 9.2. Global Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Samples, Urine Samples, Saliva Samples, Tissue Samples
  • 9.3. Global Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction, Mass Spectrometry, Nucleic Acid Amplification Tests, Next-Generation Sequencing
  • 9.4. Global Syndromic Multiplex Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Respiratory Diseases, Gastrointestinal Diseases, Sexually Transmitted Infections, Central Nervous System Diseases
  • 9.5. Global Syndromic Multiplex Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Laboratories, Hospitals, Pharmaceutical And Biotechnology Companies, Research Institutes, Other End Users
  • 9.6. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Real-Time Polymerase Chain Reaction (PCR) Systems, Microfluidic-Based Systems, Automated Sample-To-Answer Systems, Cartridge-Based Systems, Multiplex Polymerase Chain Reaction (PCR) Platforms
  • 9.7. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Assay Panels, Primers And Probes, Enzymes, Buffers And Solutions, Sample Preparation Reagents
  • 9.8. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Cloud-Based Diagnostic Platforms, Integration And Connectivity Solutions, Technical Support Services, Maintenance And Calibration Services, Training And Installation Services

10. Syndromic Multiplex Diagnostics Market Regional And Country Analysis

  • 10.1. Global Syndromic Multiplex Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Syndromic Multiplex Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Syndromic Multiplex Diagnostics Market

  • 11.1. Asia-Pacific Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Syndromic Multiplex Diagnostics Market

  • 12.1. China Syndromic Multiplex Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Syndromic Multiplex Diagnostics Market

  • 13.1. India Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Syndromic Multiplex Diagnostics Market

  • 14.1. Japan Syndromic Multiplex Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Syndromic Multiplex Diagnostics Market

  • 15.1. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Syndromic Multiplex Diagnostics Market

  • 16.1. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Syndromic Multiplex Diagnostics Market

  • 17.1. South Korea Syndromic Multiplex Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Syndromic Multiplex Diagnostics Market

  • 18.1. Taiwan Syndromic Multiplex Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Syndromic Multiplex Diagnostics Market

  • 19.1. South East Asia Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Syndromic Multiplex Diagnostics Market

  • 20.1. Western Europe Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Syndromic Multiplex Diagnostics Market

  • 21.1. UK Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Syndromic Multiplex Diagnostics Market

  • 22.1. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Syndromic Multiplex Diagnostics Market

  • 23.1. France Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Syndromic Multiplex Diagnostics Market

  • 24.1. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Syndromic Multiplex Diagnostics Market

  • 25.1. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Syndromic Multiplex Diagnostics Market

  • 26.1. Eastern Europe Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Syndromic Multiplex Diagnostics Market

  • 27.1. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Syndromic Multiplex Diagnostics Market

  • 28.1. North America Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Syndromic Multiplex Diagnostics Market

  • 29.1. USA Syndromic Multiplex Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Syndromic Multiplex Diagnostics Market

  • 30.1. Canada Syndromic Multiplex Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Syndromic Multiplex Diagnostics Market

  • 31.1. South America Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Syndromic Multiplex Diagnostics Market

  • 32.1. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Syndromic Multiplex Diagnostics Market

  • 33.1. Middle East Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Syndromic Multiplex Diagnostics Market

  • 34.1. Africa Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Syndromic Multiplex Diagnostics Market Regulatory and Investment Landscape

36. Syndromic Multiplex Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Syndromic Multiplex Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Syndromic Multiplex Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Syndromic Multiplex Diagnostics Market Company Profiles
    • 36.3.1. Roche Molecular Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Syndromic Multiplex Diagnostics Market Other Major And Innovative Companies

  • Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

38. Global Syndromic Multiplex Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Syndromic Multiplex Diagnostics Market

40. Syndromic Multiplex Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Syndromic Multiplex Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Syndromic Multiplex Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Syndromic Multiplex Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer